BCL7B Antikörper
Kurzübersicht für BCL7B Antikörper (ABIN7111913)
Target
Alle BCL7B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- BCL7B antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- B-cell CLL/lymphoma 7B
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:2000, IHC: 1:20-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- BCL7B (B-Cell CLL/lymphoma 7B (BCL7B))
-
Andere Bezeichnung
- BCL7B
-
Hintergrund
-
Synonyms: B-cell CLL/lymphoma 7 protein family member B|BCL7B
Background: Positive regulator of apoptosis. Plays a role in the Wnt signaling pathway, negatively regulating the expression of Wnt signaling components CTNNB1 and HMGA1(PubMed:25569233). Involved in cell cycle progression, maintenance of the nuclear structure and stem cell differentiation(PubMed:25569233). May play a role in lung tumor development or progression(By similarity).
-
Molekulargewicht
- 45 kDa
-
Gen-ID
- 9275
-
UniProt
- Q9BQE9
Target
-